Canada Pension Plan Investment Board
AKBA icon

Canada Pension Plan Investment Board’s Akebia Therapeutics AKBA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Sell
287,500
-35,400
-11% -$48.6K ﹤0.01% 1311
2025
Q4 		$520K Buy
+322,900
New +$676K ﹤0.01% 1292

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Canada Pension Plan Investment Board's AKBA Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Akebia Therapeutics (AKBA) stake by 11% in Q1 2026, selling an estimated $48.6K and leaving 287,500 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

Canada Pension Plan Investment Board first reported a position in AKBA in Q4 2025 and has held it in 2 quarters since. The position peaked at $520K in Q4 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Canada Pension Plan Investment Board held 287,500 shares of Akebia Therapeutics worth $400K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 35,400 Akebia Therapeutics shares in Q1 2026, an estimated $48.6K.
  • Akebia Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1311 holding.
  • Canada Pension Plan Investment Board first reported a position in Akebia Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Canada Pension Plan Investment Board's Akebia Therapeutics position peaked at $520K in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.